0001493152-22-016079.txt : 20220607
0001493152-22-016079.hdr.sgml : 20220607
20220607160546
ACCESSION NUMBER: 0001493152-22-016079
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220606
FILED AS OF DATE: 20220607
DATE AS OF CHANGE: 20220607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alvino Mark
CENTRAL INDEX KEY: 0001356828
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15771
FILM NUMBER: 221001274
MAIL ADDRESS:
STREET 1: C/O SCO SECURITIES LLC
STREET 2: 1285 AVENUE OF THE AMERICAS 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000318306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830221517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 646-813-4701
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC
DATE OF NAME CHANGE: 20140922
FORMER COMPANY:
FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960209
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2022-06-06
0
0000318306
ABEONA THERAPEUTICS INC.
ABEO
0001356828
Alvino Mark
1330 AVENUE OF THE AMERICAS,
33RD FLOOR
NEW YORK
NY
10019
1
0
0
0
Common Stock
2022-06-06
4
S
0
35000
0.1561
D
47181
D
Reflects the average weighted price of sales on June 6, 2022. The shares were sold in multiple transactions at prices ranging from $0.155 to $0.1617, inclusive. The reporting person undertakes to provide Abeona Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
/s/ Mark Alvino
2022-06-07